[go: up one dir, main page]

FI951798L - Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina - Google Patents

Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina Download PDF

Info

Publication number
FI951798L
FI951798L FI951798A FI951798A FI951798L FI 951798 L FI951798 L FI 951798L FI 951798 A FI951798 A FI 951798A FI 951798 A FI951798 A FI 951798A FI 951798 L FI951798 L FI 951798L
Authority
FI
Finland
Prior art keywords
receptor antagonists
benzofuran derivatives
benzofuran
derivatives
antagonists
Prior art date
Application number
FI951798A
Other languages
English (en)
Swedish (sv)
Other versions
FI951798A0 (fi
FI951798A7 (fi
Inventor
Peter Charles North
Sjoerd Nicolaas Wadman
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of FI951798A0 publication Critical patent/FI951798A0/fi
Publication of FI951798A7 publication Critical patent/FI951798A7/fi
Publication of FI951798L publication Critical patent/FI951798L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/04Nitro compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
FI951798A 1992-10-16 1993-10-14 Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina FI951798L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929221761A GB9221761D0 (en) 1992-10-16 1992-10-16 Chemical compounds
PCT/EP1993/002833 WO1994008993A1 (en) 1992-10-16 1993-10-14 Benzofuran derivatives as 5-ht1-like receptor antagonists

Publications (3)

Publication Number Publication Date
FI951798A0 FI951798A0 (fi) 1995-04-13
FI951798A7 FI951798A7 (fi) 1995-04-13
FI951798L true FI951798L (fi) 1995-04-13

Family

ID=10723562

Family Applications (1)

Application Number Title Priority Date Filing Date
FI951798A FI951798L (fi) 1992-10-16 1993-10-14 Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina

Country Status (24)

Country Link
US (1) US5494910A (fi)
EP (1) EP0664804A1 (fi)
JP (1) JPH06211842A (fi)
KR (1) KR940009179A (fi)
CN (1) CN1092420A (fi)
AP (1) AP425A (fi)
AU (1) AU5333794A (fi)
CA (1) CA2146569A1 (fi)
CZ (1) CZ96895A3 (fi)
EC (1) ECSP941050A (fi)
FI (1) FI951798L (fi)
GB (1) GB9221761D0 (fi)
HU (1) HUT72752A (fi)
IL (1) IL107302A0 (fi)
IS (1) IS4081A (fi)
MX (1) MX9306394A (fi)
NO (1) NO951433L (fi)
PE (1) PE51294A1 (fi)
PL (1) PL308357A1 (fi)
RU (1) RU95110110A (fi)
SI (1) SI9300542A (fi)
TW (1) TW262473B (fi)
WO (1) WO1994008993A1 (fi)
ZA (1) ZA937633B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9407447D0 (en) * 1994-04-14 1994-06-08 Glaxo Group Ltd Chemical compounds
WO1995032196A1 (en) * 1994-05-19 1995-11-30 Merck Sharp & Dohme Limited Piperazine, piperidine and tetrahydropyridine derivatives of indol-3-ylalkyl as 5-ht1d-alpha agonists
GB9610979D0 (en) * 1996-05-24 1996-07-31 Merck Sharp & Dohme Therapeutic agents
WO1998015545A1 (en) * 1996-10-08 1998-04-16 Eli Lilly And Company New serotonin 5-ht1f agonists
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
US20030198669A1 (en) * 2001-07-05 2003-10-23 R.T. Alamo Ventures I, Llc Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine
US6685951B2 (en) 2001-07-05 2004-02-03 R. T. Alamo Ventures I, Inc. Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
US20030017175A1 (en) * 2001-07-05 2003-01-23 R.T. Alamo Ventures I, Inc. Sublingual administration of dihydroergotamine for the treatment of migraine
EP3628325A1 (en) 2011-07-22 2020-04-01 The University of Chicago Treatments for migraine and related disorders
KR101443041B1 (ko) * 2013-05-06 2014-09-23 (주)하이레벤 태양광 발전설비의 효율향상설비
EP4384172A4 (en) 2021-08-12 2025-07-30 Kuleon Llc HALLUCINOGENIC AND NON-HALLUCINOGENIC SEROTONIN RECEPTOR AGONISTS AND METHODS OF MAKING AND USING THE SAME

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670105A1 (de) * 1966-07-08 1970-12-10 Byk Gulden Lomberg Chem Fab Verfahren zur Herstellung von Benzofuryl (3)-alkylaminen und deren Salzen
EP0398413A1 (en) * 1989-05-16 1990-11-22 Duphar International Research B.V "3,4-dehydropiperidine derivatives having psychotropic activity

Also Published As

Publication number Publication date
ECSP941050A (es) 1994-11-16
FI951798A0 (fi) 1995-04-13
GB9221761D0 (en) 1992-12-02
AP9300581A0 (en) 1993-10-31
ZA937633B (en) 1994-08-01
NO951433D0 (no) 1995-04-12
KR940009179A (ko) 1994-05-20
WO1994008993A1 (en) 1994-04-28
FI951798A7 (fi) 1995-04-13
IS4081A (is) 1994-04-17
MX9306394A (es) 1994-05-31
PL308357A1 (en) 1995-07-24
AU5333794A (en) 1994-05-09
AP425A (en) 1995-11-08
CZ96895A3 (en) 1995-12-13
US5494910A (en) 1996-02-27
RU95110110A (ru) 1996-12-27
HUT72752A (en) 1996-05-28
EP0664804A1 (en) 1995-08-02
NO951433L (no) 1995-04-12
CN1092420A (zh) 1994-09-21
CA2146569A1 (en) 1994-04-28
JPH06211842A (ja) 1994-08-02
TW262473B (fi) 1995-11-11
SI9300542A (en) 1994-06-30
IL107302A0 (en) 1994-01-25
PE51294A1 (es) 1995-01-06
HU9501073D0 (en) 1995-06-28

Similar Documents

Publication Publication Date Title
ATE226578T1 (de) Benzofuranderivate als tachykininantagonisten
FI943247L (fi) Piperatsiinijohdannaisia 5-HT-reseptoriantagonisteina
FI933810L (fi) Reseptorantagonister av exiterbara aminosyror
FI941178A7 (fi) 5-HT4-reseptoriantagonisteja
DE69207351D1 (de) Fibrinogen-Rezeptor-Antagoniste
FI934894A7 (fi) Fibrinogeenireseptorin antagonisteja
FI944394A7 (fi) Kinuklidiinijohdannaisia P-aineen antagonisteina
DE69325167D1 (de) Kondensierte indol-derivate als 5-ht4-rezeptor-antagonisten
DE69127791D1 (de) Diazabicyclononyl-Derivate als 5-HT3 Rezeptor Antagonisten
FI914533A7 (fi) Fibrinogeenireseptoriantagonisteja
FI914535A7 (fi) Uusia fibrinogeenireseptoriantagonisteja
FI944729L (fi) Perhydroisoindolijohdannaiset substanssi P:n antagonisteina
ATE204262T1 (de) Benzanilidderivate als 5-ht1d-antagonisten
FI951249L (fi) Serotiinireseptoriaineita
FI922143A7 (fi) Muscarinreceptorantagonister.
MX9101311A (es) Antagonistas receptores de fibrinogeno
FI943941L (fi) CCK-reseptoriantagonisteina käyttökelpoiset bentsodiatsepiinijohdannaiset
DE69418045D1 (de) Amidderivate als 5ht1d rezeptor antagonisten
KR950703530A (ko) 5-HT4 길항제(5-HT4 Antagonists)
FI951798L (fi) Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina
NO179550C (no) Tachykinin reseptorantagonister
FI943808L (fi) Triatsolopyrimidiinijohdannaisia angiotensiini II:n reseptoreiden vastavaikuttajina
FI943513L (fi) Kolekystokiniiniantagonisteina käyttökelpoisia 3-fenyyliureidoatsepin-2-oneja ja -bentsatsepin-2-oneja
FI940607A7 (fi) Imidatso(5,1-C)(1,4)bentsoksatsin-1-onijohdannaiset 5HT3-antagonisteina
FI922346A7 (fi) Muscarinreceptorantagonister.